PACULit Daily Literature Update: A Simplified Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS A Prospective Observational Study

Daily Literature Update
A Simplified Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS A Prospective Observational Study
Raimondi F, Dolce P, Veropalumbo C, et al. A Simplified Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS A Prospective Observational Study. Pediatr Pulmonol. 2025;60(7):e71206. doi:10.1002/ppul.71206.
Study Type: Secondary analysis of a multicenter, prospective observational study
Population: 175 preterm infants with Respiratory Distress Syndrome (RDS) stabilized on non-invasive continuous positive airway pressure (nCPAP)
Intervention: Regional lung ultrasound scores (rLUS) and total lung ultrasound score (tLUS) within 2 hours of life; oxygen saturation/inspired oxygen fraction ratio (SatO2/FiO2) measured
Outcomes: Predictive accuracy of rLUS and combined scores for surfactant administration need blinded to ultrasound results
- Midclavicular (MC) regional lung ultrasound score ≥2 early indicates aeration heterogeneity in RDS
- Left MC score AUC: 0.86; sensitivity: 0.79; specificity: 0.90 (cut-off = 2)
- Right MC score AUC: 0.87; sensitivity: 0.74; specificity: 0.93 (cut-off = 2)
- Combined left + right MC score improved predictive accuracy with AUC: 0.90; sensitivity: 0.82; specificity: 0.89 (cut-off = 3)
- Prediction model incorporating gestational age, SatO2/FiO2, and combined MC score achieved highest AUC: 0.95
- Regional LUS heterogeneity in early RDS underscores importance of regional assessment for surfactant decisions
Context & Related Research
- Systematic Review, 2023: LUS sensitivity 89%, specificity 86%, AUC 0.88 for surfactant need prediction (PMID:36717970)
- Study, 2020: LUS score ≥4 predicted surfactant with 96% sensitivity and 100% specificity (PMID:32674204)
- Secondary Analyses, 2022: Early surfactant administration guided by LUS reduces invasive ventilation and improves outcomes (PMID:35412891)
- Multicenter Trials, 2021: LUS use aids extending noninvasive strategies and timely surfactant replacement (PMID:33796374)
- Meta-Analysis, 2024: Validated lung ultrasound scoring systems enhance clinical decisions in neonatal RDS management (PMID:39246789)
Strengths & Limitations
Strengths | Limitations |
---|---|
Large preterm cohort across multiple centers (N=175) | Observational design limits causality |
Blinded physician surfactant decision reduces bias | Ultrasound scoring requires trained operators; inter-rater variability possible |
Novel focus on regional lung score heterogeneity | Study limited to early first 2 hours of life assessment |
Clinical Implications & Impact
Pharmacists can support prompt, precise surfactant administration by advocating for early regional lung ultrasound assessments alongside noninvasive markers (gestational age, SatO2/FiO2). This approach may reduce neonatal handling stress and optimize respiratory outcomes by guiding tailored surfactant replacement therapy.
Listen to the Podcast
A short discussion of today’s highlight.
Citations
- Raimondi F et al. Pediatr Pulmonol. 2025;60(7):e71206. PMID:40671421
- Systematic Review, 2023. PMID:36717970
- Study, 2020. PMID:32674204
- Secondary Analyses, 2022. PMID:35412891
- Multicenter Trials, 2021. PMID:33796374
- Meta-Analysis, 2024. PMID:39246789